Connect with us

BUSINESS

GrowLife Inc (OTCMKTS: PHOT) Registers $7 Million in Income in the Fiscal Year 2020

Published

on

GrowLife Inc (OTCMKTS: PHOT) has registered annual revenue of $7 million in income for the fiscal year 2020.

“We took a hard look at expenses in 2020 and were proficient to reduce our expenses by over 30%. We are fixated on constructing a cost-effective business wherever conceivable.” said GrowLife CEO Marco Hegyi. “Our cash situation is eight-fold what is was in the previous year and we have executed a deliberate plan that I trust will station GrowLife for the best future, looking past 2021 and afar.”

GrowLife sank its General & Organizational Expenditures from $7.6M in 2019 to $4.9M

The company produced $7M in income for the fiscal year 2020, notwithstanding the continuing COVID-19 epidemic. GrowLife reported a merged gross margin of 42% in 2020, up from 31% in 2019, gross returns registered an improvement of $0.4M for 2020, even with the income drop. Lastly, GrowLife in 2020, a $2.7M, or 35% savings over last year due to continuing and actual cost decreases.

The company adds two new faces to its advisory board

GrowLife has made two additions to the company’s consultative board, Mr. Lewis Swarts and Dr. Daniel Harder. Each transports exclusive experience that will help the company in increasing its CBD-rich hemp replicating business.

Mr. Swarts is a cannabis business expert, having functioned in decision-making positions at some of the domain’s most prominent cannabis and cultivation businesses for more than ten years. He brings unmatched knowledge in running working productivities for large-scale cannabis and hemp farming companies. This knowledge adds vast worth to GrowLife’s growing CBD-rich hemp clone process. Dr. Harder is a plant scientist who has devoted his profession to Botany and Agronomic Genomics. An alumna of the University of California, Berkeley, and Dr. Harder has held manifold professional, lawmaking, and board positions at highly valued plant science foundations, parks, and educational organizations.

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

BUSINESS

Metatron Inc (OTCMKTS: MRNJ) States Share Repurchase Plan

Published

on

Metatron Inc (OTCMKTS: MRNJ) has announced that its Board of Directors has approved the repurchase of up to 1 billion stocks of the company’s shared stock from time to time on the open marketplace in secretly transferred dealings. 

“The share repurchase sanction imitates our continuing promise to refine the asset worth of the company’s stock,” said CEO Joe Riehl.

Stocks to be repurchased under a Rule 10b5-1 strategy

The company’s management will schedule and amount any stocks repurchased based on its valuation of market conditions and other matters. It may also complete repurchases under a Rule 10b5-1 strategy, which would license stocks to be repurchased when the company might be prohibited from doing so under insider exchange regulations. The repurchase package may be deferred or withdrawn at any time. Any repurchased stocks will be obtainable for usage associated with its stock tactics and for other business determinations.

Metatron to partner Krave Games LLC

In other news, Metatron declared a partnership with Krave Games LLC, directed to the discharge of their first game. The new game is an addicting cosmos-themed mobile game application christened Holo Ball for the iPhone and iPad. Krave transports its advanced mobile game know-how to the table and has admission to the nets of millions of Instagram and social media groups. The two businesses plan to air a collective rollout of diverse mobile submissions geared towards gaming, entertaining, and existence classes.

With the prevalent online occurrence behind Krave games, t Holo Ball’s proclamation responses surpass anticipations, and handlers can’t seem to get adequate. Players having been giving frenzied evaluations on the game and are happy to see the following announcements from the enterprise of Krave and Metatron. Holo Ball has been out for iOS and is presently accessible on the iTunes app repository. Form 1.1 of the game was published on February 18, 2019, and presently has a 5-star score. 

Rendering to Small Biz Daily, the #1 most general iOS Mobile Submissions group is games, and in 2018 games accounted for 76% of the anticipated 92.1 Billion mobile application income. 

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Innovative Industrial Properties Inc (NYSE: IIPR) Affirms A Second-Quarter Dividend Of $1.40 Per Share Of Common Stock

Published

on

Innovative Industrial Properties Inc (NYSE: IIPR) declared that its board of directors had confirmed a second-quarter dividend of $1.40 per share of common stock. This new declaration represented an around 6% upsurge over IIP’s first quarter 2021 dividend of $1.32 per share of common stock and an around 32% increase over IIP’s second-quarter 2020 disbursement of $1.06 per share of common stock. 

The disbursement is correspondent to an annualized disbursement of $5.60 per share and is the eleventh disbursement upsurge since IIP accomplished its initial public offering in December 2016. Furthermore, IIP proclaimed today that its board of directors had confirmed a consistent quarterly disbursement of $0.5625 per share of IIP’s 9.00% Series A Cumulative Exchangeable Preferred Stock.  The disbursements will be paid on July 15, 2021, to shareholders of record after trade on June 30, 2021.

In other news proclaimed today, the company stated that it had padlocked on purchasing a property in North Adams, Massachusetts, encompassing about 70,000 square feet of manufacturing space. The acquisition price for the property was $3.1 million (discounting business charges). Simultaneous with the conclusion of the acquisition, IIP arrived into a long-term, triple-net let at the stuff with Temescal Wellness of Massachusetts, LLC (Temescal) for usage as a delimited cannabis farming and dispensation provision upon conclusion of revitalization. 

Temescal is projected to finalize added lessee developments for the property, for which IIP has settled to deliver compensation of up to $15.0 million. IIP’s entire speculation in the property is projected to be $18.1 million. As the ground-breaking real estate investment trust (REIT) for the controlled cannabis business, IIP associates with knowledgeable, accredited cannabis operatives and assists as a basis of capital by purchasing and letting back their real estate possessions, in toting to posing other imaginative real estate-based wealth answers.

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Novus Acquisition & Development (OTCMKTS: NDEV) Revenue surged 7.5% to $4,404 in Q1 2021

Published

on

Novus Acquisition & Development (OTCMKTS: NDEV) is pleased to announce its financial and operational results. It is an announcement that reflects the financial performance over the three months ended March 31, 2021. WCIG Insurance Services, LLC happens to be a well-performing wholly-owned subsidiary of the company that has supported in many ways, including transforming it into a hybrid health insurance entity. 

The financial highlights project a progressive company with a great future. This company witnessed a revenue surge of about 7.5% that represents about $4,404. The final figure stood at $63,481, which was the company’s performance over the three months ended March 31, 2021. 

The company disclosed financial details for the three months ended March 31, 2021, covering the profit margin pricing structure. It placed the figure at 34%, which is impressive according to analysts. The company experienced a net income increment that stood at $21,426 for the three months ended March 31, 2021. It was a remarkable performance compared to the three months ended March 31, 2020. The increment was by a margin of 5.5%, which translates to about $1,118. The company also announced the increase in the shareholder equity that settled at about $1,478,786 on March 31, 2021. It was a rise from $1,468,783 on December 31, 2020.

The company has also scaled the heights to develop and become the nation’s first carrier, focusing on the development and sale of cannabis products for medicinal and recreational purposes. 

The CEO of the company Frank Labrozzi opines, “As we expand our partner base that includes Third Party Administrators who have distribution contracts with major health carriers, we are seeing more interest to include Novus Cannabis MedPlan as a tool to persuade consumers to specific insurance carriers.”

Labrozzi discloses that most of the company’s associates continue onboarding and will continue offering the best support. He speaks about how they will remain focused on ramping up with the associates in the quest to expand the company’s distribution network. The company is willing to do anything to succeed. That is why it will remain open to bringing in additional associates with the target to boost its distribution network.

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Trending Stories